cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25549/examiner-c44-72987
title: Train wreck inquest, 1956

description: 26 images. Train wreck inquest, 3 February 1956. John England (Agent for Santa Fe); S. Ernest Roll; David Gardner (Engineer for Santa Fe); Frank Parrish (train engineer-defendant); inquest jury; Linwood Lester; Master Sergeant Virgil Connor; Malcomb Hobbs (sailor); Private James D. Lance; F.N. Stuppi (Santa Fe railroad); Private Richard V. Jackson; Arthur Murdock; Adolf Alexander; Virgil Cockrell; Win Stanley (Deputy Coroner); George Spickard (conductor); Homer Smith (fireman); William Hines (brakeman). (Sleeve reads: A-11701-025).; Caption slip reads: "Photographer: Monteverde. Date: 1956-02-03. Assignment: Train wreck. Jurors front row, (l to r) Ronald R. Ketcham, Fred A. McCanlies, W. Herbert Allen, C.S. McLean, [...] D. Ezell; back row, l to r. Homer L. Garrett, Earl Vaugh, [...] Sweeney, A.W. Anderson, Paul Sheely. Jury L to R. 31: Shows all witnesses seated; engineer in front center. 32/29/30: Blue ribbon jury. 8: Witness sailor Malcolmb Hobbs in back is Deputy Coroner Win Stanley - Ernie Roll. 7/21/22: Shows general scene of Santa Fe witness David Gardner, Division Eng inner & Ernie Roll pointing at rail map etc. Jury in right of pix. 27/28: Shows Ernie Roll handing photo of tracks to jury. David Gardner Santa Fe Division engineer explains to jury. 26: General view shows Arthur Murdock on stand - jury on right Adolph Alexander questioning from left. 25: L to R John England, special agent - Engineer Frank Parrish & Special Agent Virgil Cockrell of Santa Fe. 38/37: Train engineer Frank Parrish as he listens intently to testimony. 39: L to R. David Gardner explains meaning of "flange" marks on rail section (not from actual scene) Ernie Roll conducts questions. 23: Mr. F.N. Stuppi, Asst. Gen. Mgr. of Santa Fe, points to chart showing speed limits along route in question. 24: Arthur Murdock, road foreman of engineers. 19/20: Long shot shows entire room shown, Ernie Roll questioning Arthur Murdock of Santa Fe. 33/34: Geo Spickard, conductor & Homer Smith - fireman. 6: William Hines, brakeman. 5: Frank Parrish, engineer. 3: Linwood Lester, passenger on train. 4: M/Sgt. Vigril L. Connor, U.S.M.C. passenger. 14: Pvt. James D. Lance passenger from Camp Pendelton Marine base. 13: Pvt. Richard V. Jackson U.S.M.C. 50: F.N. Stuppi Asst Gen Mgr of Santa Fe. 49: F.N. Stuppi & Ernie Roll, D.A. - Roll holds Santa Fe time table & rules for employees
DOI: 10.25402/nnm.23921700
title: Antibacterial and anticancer activities of green-synthesized silver nanoparticles using<i> </i><i>Photinia glabra</i> fruit extract

description: <b>Aims: </b>We prepared <i>Photinia glabra </i>(PG) aqueous fruit extract, utilized it to synthesize silver nanoparticles (PG-Ag NPs) and evaluated the antibacterial and anticancer activities of the nanoparticles (NPs). <b>Materials & methods: </b>Silver nitrate aqueous solution was reduced to PG-Ag NPs using aqueous PG fruit extract. NP shape, size, composition and functionalization were determined using transmission electron microscopy, x-ray photoelectron spectroscopy, Fourier transform infrared and x-ray diffraction. <b>Results & conclusions: </b>PG-Ag NPs were spherical, approximately 39–77 nm-sized, furctionalized surfaces with notable antibacterial activity against both <i>Escherichia coli </i>and <i>Staphylococcus aureus, </i>with an MIC <b>&lt;</b>30 ug<b>/</b>ml and cytotoxicity toward esophageal cancer cells, with IC50 values less than 20 ug<b>/</b>ml. PGAg@ rt NPs have been shown to be a potent antibacterial and anticancer agent, and their enriched particle surfaces can be conjugated with other compounds for multibiomedical applications.
DOI: 10.25402/nnm.23921700.v1
title: Antibacterial and anticancer activities of green-synthesized silver nanoparticles using<i> </i><i>Photinia glabra</i> fruit extract

description: <b>Aims: </b>We prepared <i>Photinia glabra </i>(PG) aqueous fruit extract, utilized it to synthesize silver nanoparticles (PG-Ag NPs) and evaluated the antibacterial and anticancer activities of the nanoparticles (NPs). <b>Materials & methods: </b>Silver nitrate aqueous solution was reduced to PG-Ag NPs using aqueous PG fruit extract. NP shape, size, composition and functionalization were determined using transmission electron microscopy, x-ray photoelectron spectroscopy, Fourier transform infrared and x-ray diffraction. <b>Results & conclusions: </b>PG-Ag NPs were spherical, approximately 39–77 nm-sized, furctionalized surfaces with notable antibacterial activity against both <i>Escherichia coli </i>and <i>Staphylococcus aureus, </i>with an MIC <b>&lt;</b>30 ug<b>/</b>ml and cytotoxicity toward esophageal cancer cells, with IC50 values less than 20 ug<b>/</b>ml. PGAg@ rt NPs have been shown to be a potent antibacterial and anticancer agent, and their enriched particle surfaces can be conjugated with other compounds for multibiomedical applications.
DOI: 10.25549/examiner-c44-102044
title: McCaughey interview, 1956

description: 6 images. McCaughey interview, 12 January 1956. Gail McCaughey; Mrs. Ida McCaughey (mother).; Caption slip reads: "Daily. Photographer: Richardson. Date: 1956-01-12. Reporter: Swaim. Assignment: McCaughey interview. Pasadena. Gail McCaughey, 12, having lunch in St. Luke Hosp. Gail McCaughey and mother, Mrs. Ida McCaughey, in affectionate pose".
DOI: 10.25549/examiner-c44-102014
title: Goes to football game from hospital, 1956

description: 3 images. Goes to football game from hospital, 2 January 1956. Dale Alvord (Ambulance driver); Jack Hornbeck (on stretcher); Ray Cabe (Ambulance attendant); Doctor Vincent Myers (accompanied patient to game).; Caption slip reads: "Photographer: Olmo. Date: 1956-01-02. Reporter: Reay. Assignment: Goes to football game from hospital. 77-78: L to R - Dale Alvord, Amb. driver; Jack Hornbeck, 16, on stretcher; Ray Cabe, Amb. attendant. 1: Jack Hornbeck, 16; Dr. Vincent Myers, who accompanied patient to game".
DOI: 10.25402/nnm.24018078
title: Atorvastatin-loaded peptide amphiphiles against corneal neovascularization - supplementary material

description: <b>Background: </b>Corneal neovascularization is a sight-threatening disease. It can be treated using antiangiogenic and anti-inflammatory compounds. Therefore, atorvastatin (ATV) constitutes a suitable candidate to be administered topically. To attain suitable efficacy, ATV can be encapsulated into custom developed nanocarriers such as peptide amphiphiles. <b>Methods: </b>Three peptide amphiphiles bearing one, two or four C16-alkyl groups (mC16-Tat47-57, dC16-Tat47-57 and qC16-Tat47-57) were synthesized, characterized and loaded with ATV. Drug release and ocular tolerance were assessed as well as anti-inflammatory and antiangiogenic properties. <b>Results: </b>ATV-qC16-Tat47-57 showed higher encapsulation efficiency than mC16- Tat47-57 and dC16-Tat47-57 and more defined nanostructures. ATV-qC16-Tat47-57 showed ATV prolonged release with suitable ocular tolerance. Moreover, ATV-qC16-Tat47-57 was antiangiogenic and prevented ocular inflammation. <b>Conclusion: </b>ATV-qC16-Tat47-57 constitutes a promising topical medication against corneal neovascularization.
DOI: 10.25549/examiner-c44-101874
title: Las Vegas Helldorado Days Small Fry Parade, 1952

description: 7 images. Las Vegas Helldorado Days Small Fry Parade, 16 May 1952. Pat Coston; Mike Coston, 7 year old twins; Paradise School, Junior Frontier Riders; Las Vegas High School Rhythette; Junior Majorette. Crowd shots.; Caption slip reads: "Photographer: Sansone. Date: 1952-05-16. 15: Junior Frontier Riders, Paradise School. 9: Rhythette, Las Vegas High School. 24: Pat & Mike Coston, twins, Vegas Heights School, age 7. 23, 50: Children seated on curb, as parade passes. 51: Color Leares, leading parade. 16: Junior Majorette, (Could not get name, sorry)."
DOI: 10.25402/nnm.24018078.v1
title: Atorvastatin-loaded peptide amphiphiles against corneal neovascularization - supplementary material

description: <b>Background: </b>Corneal neovascularization is a sight-threatening disease. It can be treated using antiangiogenic and anti-inflammatory compounds. Therefore, atorvastatin (ATV) constitutes a suitable candidate to be administered topically. To attain suitable efficacy, ATV can be encapsulated into custom developed nanocarriers such as peptide amphiphiles. <b>Methods: </b>Three peptide amphiphiles bearing one, two or four C16-alkyl groups (mC16-Tat47-57, dC16-Tat47-57 and qC16-Tat47-57) were synthesized, characterized and loaded with ATV. Drug release and ocular tolerance were assessed as well as anti-inflammatory and antiangiogenic properties. <b>Results: </b>ATV-qC16-Tat47-57 showed higher encapsulation efficiency than mC16- Tat47-57 and dC16-Tat47-57 and more defined nanostructures. ATV-qC16-Tat47-57 showed ATV prolonged release with suitable ocular tolerance. Moreover, ATV-qC16-Tat47-57 was antiangiogenic and prevented ocular inflammation. <b>Conclusion: </b>ATV-qC16-Tat47-57 constitutes a promising topical medication against corneal neovascularization.
DOI: 10.25549/examiner-c44-18732
title: Water Polo at El Segundo High School, 1948

description: 7 images. Water Polo at El Segundo High School, 4 November 1948. Bob Hughs (Goalie); Harry Bisbey; Fred Reinhardt.
DOI: 10.25402/nnm.24064920
title: AS1411-conjugated doxorubicin-loaded silver nanotriangles for targeted chemo–photothermal therapy of breast cancer - supplementary data

description: <b>Background: </b>Combination therapy has attracted tremendous interest for its great potential in treating cancers. <b>Materials & methods: </b>Based on chitosan-coated silver nanotriangles, polyethylene glycol, AS1411 aptamer and doxorubicin, a multifunctional nanocomposite (AS1411-DOX-AgNTs) was constructed and characterized. Then the photothermal properties, ability to target breast cancer cells and anti-breast cancer effect of AS1411-DOX-AgNTs were evaluated. <b>Results: </b>AS1411-DOX-AgNTs were successfully fabricated and showed excellent photothermal conversion efficiency, breast cancer cell and tumor targeting ability. Compared with single treatments, the combination of AS1411-DOX-AgNTs with nearinfrared irradiation possessed the strongest anti-breast cancer effect <i>in vitro </i>and <i>in vivo</i>. <b>Conclusion: </b>AS1411-DOX-AgNTs hold great potential in targeted DOX delivery and combined chemo–photothermal therapy for breast cancer.
DOI: 10.25402/nnm.24064920.v1
title: AS1411-conjugated doxorubicin-loaded silver nanotriangles for targeted chemo–photothermal therapy of breast cancer - supplementary data

description: <b>Background: </b>Combination therapy has attracted tremendous interest for its great potential in treating cancers. <b>Materials & methods: </b>Based on chitosan-coated silver nanotriangles, polyethylene glycol, AS1411 aptamer and doxorubicin, a multifunctional nanocomposite (AS1411-DOX-AgNTs) was constructed and characterized. Then the photothermal properties, ability to target breast cancer cells and anti-breast cancer effect of AS1411-DOX-AgNTs were evaluated. <b>Results: </b>AS1411-DOX-AgNTs were successfully fabricated and showed excellent photothermal conversion efficiency, breast cancer cell and tumor targeting ability. Compared with single treatments, the combination of AS1411-DOX-AgNTs with nearinfrared irradiation possessed the strongest anti-breast cancer effect <i>in vitro </i>and <i>in vivo</i>. <b>Conclusion: </b>AS1411-DOX-AgNTs hold great potential in targeted DOX delivery and combined chemo–photothermal therapy for breast cancer.
DOI: 10.25549/examiner-c44-101857
title: Gem robbery (confessed to robbery of diamonds at Biltmore Hotel, April 26th), 1952

description: 7 images. Gem robbery (confessed to robbery of diamonds at Biltmore Hotel, April 26th), 13 May 1952. Detective Sergeant V.V. Brasher; Jack D. Sedan -- 34 years old (suspect), 208 East Fremont Place Montebello; Thad Brown (Deputy Chief of Police).
DOI: 10.25402/nnm.24081105
title: Amelioration of the therapeutic potential of gefitinib against breast cancer using nanostructured lipid carriers - supplementary dataset

description: <b>Aim: </b>This study aimed to improve the delivery and therapeutic potential of gefitinib (GTB) against breast cancer by preparing GTB-loaded, nanostructured lipid carriers (GTB-NLCs). <b>Materials & methods: </b>Box– Behnken design was used for optimization and GTB was loaded into NLCs using ultrasonication. The GTBNLCs were characterized using <i>in vitro</i>, <i>ex vivo </i>and <i>in vivo </i>studies. The anticancer efficacy of GTB-NLCs was evaluated using 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide cytotoxicity and flow cytometry on MCF-7 breast cancer cell lines. <b>Results: </b>Optimized GTB-NLCs were successfully characterized and demonstrated improved internalization and enhanced cytotoxicity compared with plain GTB. Gut permeation studies showed enhanced intestinal permeability, and pharmacokinetic analysis revealed 2.6- fold improvement in GTB oral bioavailability. <b>Conclusion: </b>GTB-NLCs effectively enhanced the therapeutic potential of GTB against breast cancer.
DOI: 10.25402/nnm.24081105.v1
title: Amelioration of the therapeutic potential of gefitinib against breast cancer using nanostructured lipid carriers - supplementary dataset

description: <b>Aim: </b>This study aimed to improve the delivery and therapeutic potential of gefitinib (GTB) against breast cancer by preparing GTB-loaded, nanostructured lipid carriers (GTB-NLCs). <b>Materials & methods: </b>Box– Behnken design was used for optimization and GTB was loaded into NLCs using ultrasonication. The GTBNLCs were characterized using <i>in vitro</i>, <i>ex vivo </i>and <i>in vivo </i>studies. The anticancer efficacy of GTB-NLCs was evaluated using 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide cytotoxicity and flow cytometry on MCF-7 breast cancer cell lines. <b>Results: </b>Optimized GTB-NLCs were successfully characterized and demonstrated improved internalization and enhanced cytotoxicity compared with plain GTB. Gut permeation studies showed enhanced intestinal permeability, and pharmacokinetic analysis revealed 2.6- fold improvement in GTB oral bioavailability. <b>Conclusion: </b>GTB-NLCs effectively enhanced the therapeutic potential of GTB against breast cancer.
DOI: 10.25402/nnm.24131907
title: Polymeric micelles loaded in situ gel with prednisolone acetate for ocular inflammation: development and evaluation supplementary dataset

description: <b>Aim: </b>Our study developed a prednisolone acetate polymeric micelles (PM) system for ocular inflammation related to allergic uveitis. <b>Methods: </b>For PM development, a thin-film hydration procedure was used. Irritation, <i>in vitro</i>, <i>ex vivo </i>transcorneal permeation, micelle size, entrapment efficiency and histology within the eye were all calculated for PM. <b>Results: </b>The optimized <i>in situ </i>gel (A4) showed superior <i>ex vivo </i>transcorneal permeation with zero-order kinetics. <b>Conclusion: </b>The developed formulation could be a promising candidate for treating anterior uveitis via topical application to the anterior segment of the eye.
DOI: 10.25549/examiner-c44-102315
title: Football, professional, 1959

description: 59 images. Football, professional, December 12 1959. Los Angeles Rams versus Baltimore Colts. (Sleeve reads: SP-12700.); Caption slip reads: "Photographer: Rustan. Date: 1959-12-12. Assignment: Rams -- Colts game. 1st quarter, 23: Pass to 84 C. complete. 24: Pass to 84 C complete, fumbled. 47: Pass to 29 R complete. 48: Rams held to 1 yd line. 45: 1st Rams touchdown. 46: conversion R. 25/26/51/52: Sid Gillman. 49: Pass to 82 R complete. 50: 2nd R field goal. 65: 86 C kick 4th down. 66: 9 Rams 9 yds. 95: Pass to 29 Rams inc. 96: field goal by R. 2nd quarter, 37: 19 C seven yds. 38: Pass C to 82, 2nd C.T.D. 43: Sid Gillman. 44: 1st Colt field goal from 47 yd line. 11/12/7/8: Sid Gillman. 3rd quarter, 22: 3rd Colt T.D., 82 complete. 21: Dev. 12 min. Ref #31 bailing out sidelines for booing. 93: Ram Matson for long run gain. 94: #66 Colts runs after intercepted pass. 91: Rams #26 2 T.D. 92: Rams field goal making score 26 to 24. 4th quarter, 29: Ref calling penalty for holding. 30: Colts 4th TD. 16: 31 Colts picks up attempt field goal and goes for 6th T.D. 43: Coach Sid Gillman Rams and Coach Weeb Ewbank Colts. 44: Sid Gillman".; Caption slip reads: "Photographer: Miller. Date: 1960-01-17. Assignment: Rams vs. Colts. 1st quarter, 122: #26 Rams carving(?) ball for. 121: Rams #82 makes large gain. 6: Colts #30 no game. 5: N.g. 106: #9 Rams makes 7 yds. 105: N.g. 36: Colt 3rd T.D. first of 3/4. 35/24: N.g. 220: Field goal 24 to 26 Rams. 219: Colt 4th T.D. 17/18/217/218: The coach".; Supplementary material reads: "Los Angeles Rams (probable offensive starting lineup). Baltimore Colts (probable offensive starting lineup)".
DOI: 10.25402/nnm.24131907.v1
title: Polymeric micelles loaded in situ gel with prednisolone acetate for ocular inflammation: development and evaluation supplementary dataset

description: <b>Aim: </b>Our study developed a prednisolone acetate polymeric micelles (PM) system for ocular inflammation related to allergic uveitis. <b>Methods: </b>For PM development, a thin-film hydration procedure was used. Irritation, <i>in vitro</i>, <i>ex vivo </i>transcorneal permeation, micelle size, entrapment efficiency and histology within the eye were all calculated for PM. <b>Results: </b>The optimized <i>in situ </i>gel (A4) showed superior <i>ex vivo </i>transcorneal permeation with zero-order kinetics. <b>Conclusion: </b>The developed formulation could be a promising candidate for treating anterior uveitis via topical application to the anterior segment of the eye.
DOI: 10.25402/nnm.24146925
title: Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine - supplementary material

description: <b>Aim: </b>To develop, characterize and evaluate an oil<b>/</b>water nanoemulsion with squalene (CTVad1) to be approved as an adjuvant for the SpiN COVID-19 vaccine clinical trials. <b>Materials & methods: </b>Critical process parameters (CPPs) of CTVad1 were standardized to meet the critical quality attributes (CQAs) of an adjuvant for human use. CTVad1 and the SpiN-CTVad1 vaccine were submitted to physicochemical, stability, <i>in vitro </i>and <i>in vivo </i>studies. <b>Results & conclusion: </b>All CQAs were met in the CTVad1 production process. SpiN- CTVad1 met CQAs and induced high levels of antibodies and specific cellular responses in <i>in vivo </i>studies. These results represented a critical step in the process developed to meet regulatory requirements for the SpiN COVID-19 vaccine clinical trial.
DOI: 10.25402/nnm.24146925.v1
title: Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine - supplementary material

description: <b>Aim: </b>To develop, characterize and evaluate an oil<b>/</b>water nanoemulsion with squalene (CTVad1) to be approved as an adjuvant for the SpiN COVID-19 vaccine clinical trials. <b>Materials & methods: </b>Critical process parameters (CPPs) of CTVad1 were standardized to meet the critical quality attributes (CQAs) of an adjuvant for human use. CTVad1 and the SpiN-CTVad1 vaccine were submitted to physicochemical, stability, <i>in vitro </i>and <i>in vivo </i>studies. <b>Results & conclusion: </b>All CQAs were met in the CTVad1 production process. SpiN- CTVad1 met CQAs and induced high levels of antibodies and specific cellular responses in <i>in vivo </i>studies. These results represented a critical step in the process developed to meet regulatory requirements for the SpiN COVID-19 vaccine clinical trial.
DOI: 10.25549/examiner-c44-11689
title: Housing projects (Rose Hills Courts), 1951

description: 6 images. Housing projects (Rose Hills Courts), July 3, 1951. Mrs. Ramona Soto -- 23 years; Christine Soto -- 2 years; Michael Soto -- 3 years. The Rose Hills Courts was a publicly funded housing project, still extant (as of August 2014) at 4466 Florizel Street. It was built in 1942, architects: Chief architect W. F. Ruck, with Claud Beelman. Landscape architect: Hammond Sadler. General contractor: L. F. Dow Company. More descriptive information with originals.
DOI: 10.25549/examiner-c44-18013
title: Society -- Los Angeles Orphans Home, 1951

description: 16 images. Society -- Los Angeles Orphans Home, 1 August 1951. Mrs. Harold McAlister; Mrs. Robert Meyler; Mrs. John Considine; Mrs. Jose R. Lacayo; Mrs. Frank Seaver; Mrs. Sven Lokrantz; Mrs. William Young; Mrs. Harold Mosby; Miss Julia Dockweiler; Mrs. Verbena Hebbard; Mrs. Clyde Burr; Odell Michael; Mrs. Maurice Hellman; Miss Alyce de Rowlet; Mrs. Robert W. Craig; Mrs. Thomas Brant, Junior; Mrs. Charles Nichols; Miss Anne Brophy; Sister Anne; Pinky Belindez; Linda Matera; Elizabeth Csendes; Sister Mary Rose.; Caption slip reads: "Photographer: McCarty. Date: 1951-08-01. 9 &10: Left to right: 1. Mrs. Harold McAlister; 2. Mrs. Robert Meyer; 3. Mrs. John Considine; 4. Mrs. Jose R. Lacayo; 5. Mrs. Frank Seaver; 6. Mrs. Sven Lokrantz; 7. Mrs. William Young; 8. Miss Tulia Dockweiler; 9. Mrs. Harold Mosby; 10. Mrs. Verbena Hebbard."
DOI: 10.25402/nnm.24155541
title: Delivering drugs to tubular cells and organelles: the application of nanodrugs in acute kidney injury - supplementary table

description: Acute kidney injury (AKI) is a common clinical syndrome with limited treatment options and high mortality rates. Proximal tubular epithelial cells (PTECs) play a key role in AKI progression. Subcellular dysfunctions, including mitochondrial, nuclear, endoplasmic reticulum and lysosomal dysfunctions, are extensively studied in PTECs. These studies have led to the development of potential therapeutic drugs. However, clinical development of those drugs faces challenges such as low solubility, short circulation time and severe systemic side effects. Nanotechnology provides a promising solution by improving drug properties through nanocrystallization and enabling targeted delivery to specific sites. This review summarizes advancements and limitations of nanoparticle-based drug-delivery systems in targeting PTECs and subcellular organelles, particularly mitochondria, for AKI treatment.
DOI: 10.25402/nnm.24155541.v1
title: Delivering drugs to tubular cells and organelles: the application of nanodrugs in acute kidney injury - supplementary table

description: Acute kidney injury (AKI) is a common clinical syndrome with limited treatment options and high mortality rates. Proximal tubular epithelial cells (PTECs) play a key role in AKI progression. Subcellular dysfunctions, including mitochondrial, nuclear, endoplasmic reticulum and lysosomal dysfunctions, are extensively studied in PTECs. These studies have led to the development of potential therapeutic drugs. However, clinical development of those drugs faces challenges such as low solubility, short circulation time and severe systemic side effects. Nanotechnology provides a promising solution by improving drug properties through nanocrystallization and enabling targeted delivery to specific sites. This review summarizes advancements and limitations of nanoparticle-based drug-delivery systems in targeting PTECs and subcellular organelles, particularly mitochondria, for AKI treatment.
DOI: 10.25549/examiner-c44-53041
title: Football -- North - South Shrine Coliseum, 1958

description: 8 images. Football -- North - South Shrine Coliseum, 30 July 1958. Pete Yoder; Don Kasso; Alan Shields.; Caption slips continue: "Photographer: Rustan. Date: 1958-07-30. Assignment: North - South Shrine. 51: Alan Shields, 35 South to 1 yd line. 94: 44 South touchdown(?). 93: 36 South makes conversion point after touchdown. 1st Quarter. 3: Pete Yoder, 36 South returns kickoff. 4: Don Kasso, 42 North, first down 22 yard run. 25: 33 N 6 yards. 26: 33 N tried but(?) to 1 yd line. 52: 33 touchdown North.".